The Underestimated Occupational Impact of Pelvic Pain

May 30, 2026 | Health Tech

Image Source: Tap. Health/Maxine Lindsay
Written by: Maxine Lindsay, NZROT
On behalf of: Tap. Health

When people think about pelvic pain, they often think about symptoms.

Cramping.

Heavy bleeding.

Fatigue.

Bloating.

Pain during intimacy. Bladder urgency.

What is discussed far less is the occupational impact of pelvic pain: the way pain changes a person’s ability to participate in everyday life.

As an Occupational Therapist and founder of a pelvic pain support company, I have seen firsthand how persistent pain affects not just physical comfort, but identity, confidence, routines, relationships, work capacity and energy conservation.

Many people with pelvic pain become experts in functioning while unwell. They get to know themselves, their environments and their tasks on a deeper level.

They learn which meetings they can survive without pain relief. They keep heat packs & TENS machines in their office desks. They calculate how far they are from a bathroom. They weigh up whether attending a social event is worth the physical recovery that may follow.

For mothers, pain does not pause parenting demands. For students, it does not pause deadlines. For people in the workforce, it rarely pauses expectations.

This is one reason pelvic pain can become so emotionally exhausting. People are often expected to continue performing at full capacity while managing symptoms that can significantly disrupt concentration, sleep, mobility and quality of life.

Historically, many pain support products have also failed to consider this reality. Pain management has often been designed around resting, stopping or staying home, rather than helping people continue participating in meaningful activities safely and comfortably.

This gap became increasingly obvious to me while navigating pelvic pain personally and professionally. I saw how many people were trying to adapt generic or clinical pain relief products into everyday life with limited success.

The reality is that people do not only experience pain on the couch. They experience it while commuting, parenting, studying, working, shopping, exercising and existing in public spaces.

That understanding ultimately shaped the development of Tap. Health and Tap 2.0, a wearable TENS device designed specifically for pelvic pain and real-life use. The goal was not simply symptom reduction, but improved participation: helping people feel more capable of moving through daily life with greater support. The proof is in the uptake from pelvic specialist clinics and physiotherapy clinics who are recommending Tap 2.0 TENS to their patients.

 

Occupational Therapy often focuses on adapting environments, tools and routines to improve a person’s ability to participate in meaningful occupations. Pelvic pain support deserves the same thinking.

The conversation around pelvic pain should not only focus on whether people are surviving their symptoms. It should also ask whether they are being properly supported to live their lives.

As awareness around women’s health continues to grow globally, there is an opportunity to rethink what pain support looks like practically, emotionally and socially.

Pain management should not require disappearing from everyday life. Thoughtful, wearable and evidence-informed support options can play an important role in helping people participate more fully in work, relationships, parenting and the activities that matter most to them.

May is pelvic pain awareness month, an important time to reflect on this conversation.

 

Author Bio

Maxine Lindsay, NZROT, Founder Tap. Health

 

Maxine Lindsay is an occupational therapist, women’s health educator, and health tech founder passionate about bridging the gap between clinical care and everyday life. Her work focuses on improving access to evidence-based education, innovative health solutions, and better support for people navigating pelvic pain and women’s health conditions.

    References: None.
    The views expressed in this article are those of the author and do not represent the editorial position of Life Science Daily News. Contributors may have a commercial interest in the topics they write about. For more information see our Contributor Policy

    Articles that may be of interest

    The Silent Clock in Your Arteries

    The Silent Clock in Your Arteries

    The Silent Clock in Your Arteries: Why Vascular Aging Is the Heart Health Crisis We're Missing We are living in an era of extraordinary innovation in heart health. Precision diagnostics. AI-guided therapies. Wearables that track everything from rhythm to recovery. And...

    read more
    Climate-Sensitive Maternal Mental Health Screening

    Climate-Sensitive Maternal Mental Health Screening

    A pregnant woman may never walk into a clinic saying climate change is affecting her mental health. She may say she has not slept through the heat. She may say flooding made her miss an antenatal visit. She may say food costs have changed what she can feed her family....

    read more
    Agentic AI in Drug Discovery: Why Big Pharma is All in

    Agentic AI in Drug Discovery: Why Big Pharma is All in

    When Eli Lilly signed a deal worth up to $2.75 billion with AI drug developer Insilico Medicine in March 2026, it was the latest in a cascade of nine-figure and ten-figure commitments from the world’s largest pharmaceutical companies to a single emerging technology....

    read more

    Articles that may be of interest

    The Silent Clock in Your Arteries

    The Silent Clock in Your Arteries

    The Silent Clock in Your Arteries: Why Vascular Aging Is the Heart Health Crisis We're Missing We are living in an era of extraordinary innovation in heart health. Precision diagnostics. AI-guided therapies. Wearables that track everything from rhythm to recovery. And...

    read more
    Climate-Sensitive Maternal Mental Health Screening

    Climate-Sensitive Maternal Mental Health Screening

    A pregnant woman may never walk into a clinic saying climate change is affecting her mental health. She may say she has not slept through the heat. She may say flooding made her miss an antenatal visit. She may say food costs have changed what she can feed her family....

    read more
    Agentic AI in Drug Discovery: Why Big Pharma is All in

    Agentic AI in Drug Discovery: Why Big Pharma is All in

    When Eli Lilly signed a deal worth up to $2.75 billion with AI drug developer Insilico Medicine in March 2026, it was the latest in a cascade of nine-figure and ten-figure commitments from the world’s largest pharmaceutical companies to a single emerging technology....

    read more